ACM
TRIL

Aquatic Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History

Aquatic Capital Management’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-700
Closed – – 1665
2021
Q4 		$0 Buy
+700
New +$12.5K ﹤0.01% 1101

Aquatic Capital Management's TRIL Position: Q1 2022 in Review

Aquatic Capital Management sold out of Trillium Therapeutics Inc. (TRIL) in Q1 2022, closing a stake of 700 shares.

Aquatic Capital Management first reported a position in TRIL in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 0 funds tracked by Wall St. Rank hold TRIL as of Q1 2022.

  • Aquatic Capital Management reported no remaining Trillium Therapeutics Inc. position as of Q1 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 700 Trillium Therapeutics Inc. shares in Q1 2022.
  • Aquatic Capital Management first reported a position in Trillium Therapeutics Inc. in Q4 2021 and held it in 1 quarter.
  • Aquatic Capital Management's Trillium Therapeutics Inc. position peaked at $0 in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q1 2022.

Based on Aquatic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.